Interpretation of the Individual Effect Under Treatment Spillover

被引：7

作者：

Crawford, Forrest W. ^{[1
,2
,3
]}

Morozova, Olga ^{[1
]}

Buchanan, Ashley L. ^{[4
]}

Spiegelman, Donna ^{[1
,5
,6
]}

机构：

[1] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA

[2] Yale Univ, Grad Sch Arts & Sci, Dept Ecol & Evolutionary Biol, New Haven, CT USA

[3] Yale Univ, Sch Management, New Haven, CT USA

[4] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA

[5] Yale Univ, Grad Sch Arts & Sci, Dept Stat & Data Sci, New Haven, CT USA

[6] Yale Univ, Ctr Methods Implementat & Prevent Sci, Sch Publ Hlth, New Haven, CT USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2019年 / 188卷 / 08期

基金：

美国国家卫生研究院;

关键词：

causal inference; dissemination; injection drug use; interference; randomization; spillover; CORONARY-HEART-DISEASE; RELIGIOUS SERVICE ATTENDANCE; DIETARY-SUPPLEMENT USE; VITAMIN-E CONSUMPTION; CAUSAL INFERENCE; MENDELIAN RANDOMIZATION; DISCRIMINANT FUNCTION; LUNG-CANCER; US ADULTS; EPIDEMIOLOGY;

D O I：

10.1093/aje/kwz108

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Some interventions are intended to benefit both individuals and the groups to which they belong. When a treatment given to one person exerts a causal effect on others, the treatment is said to exhibit spillover, dissemination, or interference. However, defining meaningful causal effects under spillover can be challenging. In this commentary, we discuss the meaning of the "individual effect," a quantity proposed to summarize the effect of treatment on the person who receives it, when spillover may be present.

引用

页码：1407 / 1419

页数：13

共 138 条

[61] STANDARDIZATION OF RISK RATIOS [J].